(Q28165456)

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

14 March 2024

author name string

Rosanne Aleong

1

0 references

Nicole Aumont

2

0 references

Doris Dea

3

0 references

Judes Poirier

full work available at URL

4

0 references

language of work or name

English

0 references

publication date

September 2003

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1460-9568.2003.02869.x

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1460-9568.2003.02869.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

European Journal of Neuroscience

14 March 2024

published in

0 references

volume

18

0 references

issue

6

0 references

page(s)

1428-38

0 references

cites work

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Effects of modifications of alpha-crystallin on its chaperone and other properties

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Recycling of apolipoprotein E in mouse liver

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia.

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Anti-inflammatory drugs protect against Alzheimer disease at low doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Kinetic basis for selective inhibition of cyclo-oxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Alterations in apolipoprotein E expression during aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Effects of pro-inflammatory cytokines on apolipoprotein E secretion by a human astrocytoma cell line (CCF-STTG1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Complement gene expression in human brain: comparison between normal and Alzheimer disease cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Specific regional transcription of apolipoprotein E in human brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Assay of acetylsalicylic acid and three of its metabolites in human plasma and urine using non-aqueous capillary electrophoresis with reversed electroosmotic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E suppresses glial cell secretion of TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Expression of apolipoprotein E mRNA in rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02869.X

Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Relationship to analgesic activity

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Normalization and subtraction: two approaches to facilitate gene discovery

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Processing Data for Outliers

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

14 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

14 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Anti-inflammatory drugs and Alzheimer disease.

14 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

14 March 2024

48

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians

14 March 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

MHC class II-positive microglia in human brain: association with Alzheimer lesions

14 March 2024

52

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Apolipoprotein E, synaptic plasticity and Alzheimer's disease

14 March 2024

59

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs

14 March 2024

64

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Acetylation of prostaglandin synthase by aspirin

14 March 2024

65

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia.

14 March 2024

66

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Association of Apolipoprotein E Polymorphism and Concentration with Serum Lipids and Apo-lipoprotein Level in the Chinese fromShanghai

14 March 2024

68

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

14 March 2024

69

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

14 March 2024

73

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

Genetics of the apolipoprotein E system in man

14 March 2024

75

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions.

14 March 2024

81

1 reference

https://api.crossref.org/works/10.1046/J.1460-9568.2003.02869.X

14 March 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

14511323

1 reference

Consolidated OpenCitations Corpus – April 2017